Keyword Index
Browse for an article via relevant keywords across our entire electronic archive
Search results for: V
Results 1 - 10 of 140 shown below
-
Src tyrosine kinase augments taxotere-induced apoptosis through enhanced expression and phosphorylation of Bcl-2
doi:10.1038/sj.bjc.6600080
-
A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families
doi:10.1054/bjoc.2001.1944
-
Recovery of
-chain expression and changes in spontaneous IL-10 production after PSA-based vaccines in patients with prostate cancerdoi:10.1038/sj.bjc.6600039
-
In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouse
doi:10.1038/sj.bjc.6601028
-
Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology
advance online publication, 2005-10-11 00:00:00.000;
doi:10.1038/sj.bjc.6602736
-
Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity
advance online publication, 2006-09-05 00:00:00.000;
doi:10.1038/sj.bjc.6603341
-
Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK
advance online publication, 2006-12-05 00:00:00.000;
doi:10.1038/sj.bjc.6603501
-
Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland
advance online publication, 2007-01-23 00:00:00.000;
doi:10.1038/sj.bjc.6603575
-
Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening
advance online publication, 2008-01-08 00:00:00.000;
doi:10.1038/sj.bjc.6604162
-
Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India
advance online publication, 2008-07-08 00:00:00.000;
doi:10.1038/sj.bjc.6604462
-
Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo
doi:10.1038/sj.bjc.6690538
-
Infections, vaccinations, and the risk of childhood leukaemia
doi:10.1038/sj.bjc.6690548
-
Infant vaccinations and risk of childhood acute lymphoblastic leukaemia in the USA
doi:10.1038/sj.bjc.6690668
-
Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma
doi:10.1054/bjoc.1999.1088
-
Haemophilus influenzae type b vaccine formulation and risk of childhood leukaemia
doi:10.1038/sj.bjc.6600489
-
Haemophilus influenzae type B vaccination and risk of childhood leukaemia in a vaccine trial in Finland
doi:10.1054/bjoc.2000.1382
-
Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma
doi:10.1038/sj.bjc.6600063
-
Generation of dendritic cell-based vaccines for cancer therapy
doi:10.1038/sj.bjc.6600316
-
Isolation and characterisation of a human anti-idiotypic scFv used as a surrogate tumour antigen to elicit an anti-HER-2/neu humoral response in mice
advance online publication, 2004-04-27 00:00:00.000;
doi:10.1038/sj.bjc.6601825
-
Targeting cytotoxic T lymphocytes for cancer immunotherapy
advance online publication, 2004-07-13 00:00:00.000;
doi:10.1038/sj.bjc.6602022
-
Specificity analysis of sera from breast cancer patients vaccinated with MUC1-KLH plus QS-21
doi:10.1038/sj.bjc.6690288
-
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells
doi:10.1054/bjoc.2001.2160
-
Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens
doi:10.1054/bjoc.2001.1801
-
Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes
doi:10.1038/sj.bjc.6600223
-
Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer
advance online publication, 2007-03-20 00:00:00.000;
doi:10.1038/sj.bjc.6603695
-
Peptide HER2(776-788) represents a naturally processed broad MHC class II-restricted T cell epitope
doi:10.1054/bjoc.2001.2089
-
Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites
doi:10.1038/sj.bjc.6600870
-
A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy
advance online publication, 2005-04-26 00:00:00.000;
doi:10.1038/sj.bjc.6602552
-
Survival Analysis Part IV: Further concepts and methods in survival analysis
doi:10.1038/sj.bjc.6601117
-
Validation of the English and Chinese versions of the Quick-FLIC quality of life questionnaire
advance online publication, 2005-02-08 00:00:00.000;
doi:10.1038/sj.bjc.6602399
-
Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP
doi:10.1038/sj.bjc.6603220
-
Interpretation of microarray data in cancer
advance online publication, 2007-03-06 00:00:00.000;
doi:10.1038/sj.bjc.6603673
-
Development and validation of the Cancer Dyspnoea Scale: a multidimensional, brief, self-rating scale
doi:10.1054/bjoc.1999.1002
